Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adrienne van Beckhoven"'
Autor:
John M, Timmerman, Gita, Singh, Gary, Hermanson, Peter, Hobart, Debra K, Czerwinski, Behnaz, Taidi, Ranjani, Rajapaksa, Clemens B, Caspar, Adrienne, Van Beckhoven, Ronald, Levy
Publikováno v:
Cancer research. 62(20)
B-cell lymphomas express tumor-specific immunoglobulin, the variable regions of which [idiotype (Id)] can serve as a target for active immunotherapy. Promising results have been obtained in clinical studies of Id vaccination using Id proteins.However
Autor:
Adrienne van Beckhoven, Thomas A. Davis, Edgar G. Engleman, Behnaz Taidi, Craig Okada, Claudia Benike, Debra K. Czerwinski, Ronald Levy, Tina Marie Liles, Ranjani Rajapaksa, John M. Timmerman, Frank J. Hsu, Clemens B. Caspar, Zheng Mei Hao
Publikováno v:
Blood. 99(5)
Tumor-specific clonal immunoglobulin expressed by B-cell lymphomas (idiotype [Id]) can serve as a target for active immunotherapy. We have previously described the vaccination of 4 patients with follicular lymphoma using dendritic cells (DCs) pulsed
Autor:
Adrienne van Beckhoven, Thomas A. Davis, Ronald Levy, Claudia Benike, Frank J. Hsu, Tina Marie Liles, Clemens B. Caspar, Edgar G. Engleman, Debra K. Czerwinski, Behnaz Taidi
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 7(9)
Vaccination with the idiotype (Id) protein derived from B-cell malignancies can produce Id-specific immune responses that correlate with improved remission duration and survival rates in patients with follicular non-Hodgkin's lymphoma (NHL). A state
Autor:
Karl G. Blume, Keith Stockerl-Goldstein, Susanne Auffermann-Gretzinger, Ranjani Rajapaksa, Arcangelo Liso, Ronald Levy, Claudia Benike, Edgar G. Engleman, Adrienne van Beckhoven, Volker L. Reichardt
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 6(6)
The idiotype (Id) determinants on the multiple myeloma immunoglobulin can serve as tumor-specific antigens. An anti-Id immune response may stem the growth of the malignant clone. We report on 26 patients treated at our institution with high-dose chem